Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

9.08
-0.1700-1.84%
Post-market: 9.130.0460+0.51%19:30 EDT
Volume:1.80M
Turnover:16.48M
Market Cap:1.66B
PE:-89.02
High:9.34
Open:9.34
Low:9.04
Close:9.25
52wk High:11.33
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:0.28
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-170.07
PE(LYR):2,831.31

Loading ...

Xeris Biopharma Grants Inducement Equity Awards Covering 352,170 Shares to 60 New Employees

Reuters
·
18 hours ago

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
18 hours ago

Xeris Biopharma Chief Legal Officer Beth Hecht Disposes of 16,666 Shares Worth $156,797

Reuters
·
18 hours ago

Deals of the Day-Mergers and Acquisitions

Reuters
·
Sep 30

Xeris Biopharma COO Kevin McCulloch Sells $250,000 in Common Shares

Reuters
·
Sep 30

Xeris Biopharma Rises on Report of Lundbeck Takeover Interest

Reuters
·
Sep 30

Lundbeck exploring acquisition of Xeris, Bloomberg reports

TIPRANKS
·
Sep 30

Lundbeck is Said to Express Interest in Buying Xeris Biopharma - Bloomberg News

THOMSON REUTERS
·
Sep 30

Market Chatter: Lundbeck Said to Explore Potential Xeris Biopharma Acquisition

MT Newswires Live
·
Sep 30

Xeris Biopharma tells Bloomberg ‘not for sale’

TIPRANKS
·
Sep 30

Lundbeck Said to Explore Potential Xeris Biopharma Acquisition, Bloomberg Reports

MT Newswires Live
·
Sep 30

H.C. Wainwright Remains a Buy on Xeris Pharmaceuticals (XERS)

TIPRANKS
·
Sep 22

Xeris Biopharma is Maintained at Outperform by Leerink Partners

Dow Jones
·
Sep 10

Analysts Conflicted on These Healthcare Names: Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS)

TIPRANKS
·
Sep 10

Xeris Biopharma price target raised to $16 from $12 at Leerink

TIPRANKS
·
Sep 10

Medmix Drug Delivery Unit Partners with Xeris on XP-8121 D-Flex Pen Injector Development

Reuters
·
Sep 10

Xeris Biopharma hosts webinar on XP-8121 development program

TIPRANKS
·
Sep 09

Xeris Targets Phase 3 Start for Once-Weekly Levothyroxine Candidate XP-8121 by Year-End

Reuters
·
Sep 09

Xeris Biopharma CFO Steven Pieper Disposes of 5,000 Shares Worth $42,500

Reuters
·
Sep 02

Xeris to Host XP-8121 Hypothyroidism Program Overview Webinar

Reuters
·
Aug 26